Detailed Information

Cited 16 time in webofscience Cited 22 time in scopus
Metadata Downloads

Inverse Association Between Serum Non-High-Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis

Authors
Chang, Tae IkStreja, ElaniKo, Gang JeeNaderi, NedaRhee, Connie M.Kovesdy, Csaba P.Kashyap, Moti L.Vaziri, Nosratola D.Kalantar-Zadeh, KamyarMoradi, Hamid
Issue Date
19-Jun-2018
Publisher
WILEY
Keywords
dyslipidemia; hemodialysis; high-density lipoprotein; mortality; non-high-density lipoprotein
Citation
JOURNAL OF THE AMERICAN HEART ASSOCIATION, v.7, no.12
Indexed
SCIE
SCOPUS
Journal Title
JOURNAL OF THE AMERICAN HEART ASSOCIATION
Volume
7
Number
12
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/3425
DOI
10.1161/JAHA.118.009096
ISSN
2047-9980
Abstract
Background-There is accumulating evidence that serum levels of non-high-density lipoprotein cholesterol (non-HDL-C) are a more accurate predictor of cardiovascular outcomes when compared with low-density lipoprotein cholesterol. However, we recently found that higher serum concentrations of triglycerides are associated with better outcomes in patients undergoing hemodialysis. Therefore, we hypothesized that the association of serum levels of non-HDL-C (which includes triglyceride-rich lipoproteins) with outcomes may also be different in patients undergoing hemodialysis when compared with other patient populations. Methods and Results-We studied the association of baseline and time-dependent serum levels of non-HDL-C with all-cause and cardiovascular mortality using Cox proportional hazard regression models in a nationally representative cohort of 50 118 patients undergoing incident hemodialysis from January 1, 2007, to December 31, 2011. In time-dependent models adjusted for case mix and surrogates of malnutrition and inflammation, a graded inverse association between non-HDL-C level and mortality was demonstrated with hazard ratios (95% confidence intervals) of the lowest (< 60 mg/dL) and highest (>= 160 mg/dL) categories: 1.88 (1.72-2.06) and 0.73 (0.64-0.83) for all-cause mortality and 2.07 (1.78-2.41) and 0.75 (0.60-0.93) for cardiovascular mortality, respectively (reference, 100-115 mg/dL). In analyses using baseline values, non-HDL-C levels < 100 mg/dL were also associated with significantly higher mortality risk across all levels of adjustment. Similar associations were found when evaluating non-HDL/HDL cholesterol ratio and mortality, with the highest all-cause and cardiovascular mortality being observed in patients with decreased non-HDL/HDL-C ratio (< 2.5). Conclusions-Contrary to the general population, decrements in non-HDL-C and non-HDL/HDL cholesterol ratio were paradoxically associated with increased all-cause and cardiovascular mortality in patients undergoing incident hemodialysis. The underlying mechanisms responsible for these associations await further investigation.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Nephrology and Hypertension > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Ko, Gang Jee photo

Ko, Gang Jee
Guro Hospital (Department of Nephrology and Hypertension, Guro Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE